Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
A Prospective,Randomized,Double-blind,Comparative Clinical Study of Efficacy and Safety of a Biosimilar Adalimumab with Innovator Product in Patients with Active Rheumatoid Arthritis on a Stable Dose of Methotrexate